Squamous Cell Skin Cancer

Cutaneous squamous cell carcinoma is another type of skin cancer. It starts in the squamous cells, which are flat cells that make up the outer layer of your skin. This type of cancer is less dangerous than melanoma, but it can still spread if left untreated. It often appears as a firm red nodule, a flat sore that doesn't heal, or a scaly patch.

Condition

What people with Squamous Cell Skin Cancer report

Every report comes from a Lived member, sent anonymously.

Have you had Mohs Surgery for Squamous Cell Skin Cancer?

NameHow it went

About Squamous Cell Skin Cancer

What It Is

Squamous cell skin cancer, also called cutaneous squamous cell carcinoma, is a cancer that starts in the flat cells (squamous cells) that make up the outer layer of the skin. Along with basal cell carcinoma, it is one of the two most common skin cancers. It usually appears on skin that has had years of sun exposure, such as the face, ears, lower lip, scalp, neck, hands, arms and lower legs. It often shows up as a firm red or skin-colored bump, a rough scaly patch, a sore that does not heal (or heals and then comes back), or a growth that looks like a wart or a small horn. It may crust, bleed, itch or feel tender, but many cause no symptoms at all. On darker skin it can look brown or black, and it can develop in places that get little sun. Most squamous cell skin cancers grow slowly and are found while still confined to the skin, when treatment usually cures them. Left untreated, some grow deeper into nerves, muscle, cartilage or bone, and occasionally they spread to nearby lymph nodes or other organs. That possibility is what separates it from a harmless skin growth, and why a suspicious spot is worth checking. It is a different cancer from melanoma and does not turn into melanoma.

Causes & Risk Factors

Most squamous cell skin cancer is caused by ultraviolet (UV) radiation from the sun or from tanning beds and sunlamps, which damages skin cells over many years. That is why it usually appears on sun-exposed skin and becomes more common with age; many people are 60 or older when it is diagnosed. Indoor tanning can bring it on years or even decades earlier. Risk is highest in people with light skin that burns easily, light-colored eyes, or red or blond hair, and in people who have had many sunburns or spend a lot of time outdoors, including for work. People of all skin colors can develop it, and in people with darker skin it is the most common skin cancer. Actinic keratoses, rough scaly patches caused by sun damage, are not cancer but sometimes turn into squamous cell carcinoma. A weakened immune system raises risk sharply, most of all in people taking anti-rejection medicines after an organ transplant, and in them the cancer tends to be more aggressive. Other contributors include a previous skin cancer, an old scar (especially from a burn), a wound that has not healed for months or years, past radiation treatment, arsenic exposure and rare inherited conditions such as xeroderma pigmentosum. Having a risk factor does not mean someone will develop this cancer, and some people with no known risk factor do.

How It's Diagnosed

Diagnosis starts with a skin exam, usually by a dermatologist (a doctor who specializes in skin), along with questions about sun exposure, past skin cancers and anything that weakens the immune system, such as an organ transplant. Appearance alone cannot confirm skin cancer, so the doctor takes a biopsy: after numbing the area, they shave off, punch out or cut out some or all of the spot, and a pathologist examines it under a microscope. The biopsy report does more than name the cancer. It says whether the cancer is in situ, meaning still confined to the top layer of skin (also called Bowen's disease or stage 0), or invasive, meaning it has grown into deeper layers. It may also note high-risk features, such as cells that are poorly differentiated (they look less like normal skin cells, which tends to mean faster growth) or cancer growing along a nerve. These details help predict how likely the cancer is to come back or spread, and they guide the choice of treatment. After diagnosis, a full-body skin check looks for other skin cancers. When a cancer looks higher risk, the doctor also feels the nearby lymph nodes and may order imaging (an ultrasound, a computed tomography (CT) scan or magnetic resonance imaging (MRI)) or a lymph node biopsy, to see how deep it goes and whether it has spread. The standard staging system covers cancers of the head and neck.

Treatment Options

The goal is to remove or destroy all of the cancer. Most squamous cell skin cancers are treated in a dermatologist's office while the person is awake, with the area numbed. The choice depends on the cancer's size, depth, location and risk features, and on the person's overall health. Surgical excision cuts out the tumor with a margin of normal skin, which is then checked under a microscope. Mohs surgery removes the cancer one thin layer at a time, examining each layer while the person waits, until no cancer cells remain. Because it spares as much healthy skin as possible, it is often used on the face, ears, eyelids, scalp, hands and genitals, and for cancers that have come back, have unclear borders or carry a higher risk. A small, shallow, low-risk cancer on the trunk or limbs may instead be scraped away and its base treated with an electric current (curettage and electrodesiccation). For an in situ cancer, freezing with liquid nitrogen (cryosurgery) or photodynamic therapy, a light-activated medicine applied to the skin, can be options, especially when surgery is not suitable. Depending on its size and location, the wound may be left to heal on its own, stitched or surgically reconstructed, and every method leaves some scar. Radiation therapy can be the main treatment when surgery is not possible or too risky. It is also often added after surgery when cancer cells remain or the risk of return is high. It is usually given in several sessions over days or weeks. Advanced cancer, meaning it has grown into deeper tissue or spread to lymph nodes or beyond, is usually managed by a team that may include surgical, radiation and medical oncologists. When surgery and radiation cannot cure it, immunotherapy drugs called checkpoint inhibitors help the immune system recognize and attack cancer cells. Three are approved for this cancer and given by IV infusion: cemiplimab (Libtayo), pembrolizumab (Keytruda) and cosibelimab (Unloxcyt). In the trials that led to approval of cemiplimab, about half of people with advanced squamous cell skin cancer had their tumors shrink, often for six months or longer. Cemiplimab is also approved after surgery and radiation for adults at high risk of the cancer returning. Because these drugs take a brake off the immune system, they can cause inflammation in organs such as the lungs, bowel, liver, hormone glands and skin, and they can trigger rejection of a transplanted organ, which makes the decision especially careful for transplant recipients. Chemotherapy and clinical trials are other options.

What to Expect

The outlook for squamous cell skin cancer that is found early and properly treated is excellent: more than 90% of people are cured. Recovery after office surgery mainly involves caring for the wound at home as instructed. Cancers that have grown deep or spread need more treatment and closer follow-up, and immunotherapy has helped some people with advanced disease live longer. Having had one skin cancer raises the chance of another, of the same or a different type. Squamous cell carcinoma also occasionally comes back at or near the treated site or in a nearby lymph node, usually within five years. Follow-up skin checks are therefore part of life after treatment. How often depends on the cancer's risk; people at high risk, including transplant recipients, may be seen as often as every one to three months at first, sometimes with imaging. A dermatologist will usually teach regular skin self-exams, using a mirror or a partner for hard-to-see areas. Sun protection remains worthwhile after a skin cancer because it helps prevent new ones: shade during the midday hours, long sleeves and a wide-brimmed hat, a broad-spectrum, water-resistant sunscreen with a sun protection factor (SPF) of 30 or higher reapplied every two hours and after swimming or sweating, and no tanning beds.

When to Seek Help

Arrange a skin check for any new or changing spot that is scaly, crusted, firm and growing, wart-like or horn-like, or a sore that does not heal or keeps coming back. People with a weakened immune system or several past skin cancers benefit from regular scheduled skin exams. Contact the dermatologist promptly, without waiting for the next appointment, about a lump, bump or sore on or near a treatment scar, a new lump or swelling in a nearby lymph node, or a growth, bumps or bleeding in an old scar or long-standing wound. Anyone receiving immunotherapy should report new diarrhea, abdominal pain, fever or unusual fatigue to the cancer team right away, so that immune-related side effects can be caught and treated early.

Questions to Ask Your Doctor

  1. 1.Is this cancer in situ or invasive, and does my biopsy report show any features that raise the risk of it coming back or spreading?
  2. 2.Why do you recommend this treatment for my cancer rather than Mohs surgery, excision or radiation?
  3. 3.What kind of scar should I expect, and how should I care for the wound while it heals?
  4. 4.How often should I have skin checks, and what should I look for between visits?
  5. 5.Do my immune system, medicines or transplant history change my risk or my treatment plan?

Last reviewed • Oct 2026

Educational content, not medical advice.